Hybrid nucleic acid switches
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsBruce A. Shapiro, Paul J. Zakrevsky
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsBruce A. Shapiro, Paul J. Zakrevsky
Estimating the term…
Disclosed are DNA/RNA hybrid nucleic acid nanoparticles comprising at least one trigger toehold or at least one exchange toehold, wherein each at least one trigger toehold and the at least one exchange toehold independently comprise DNA and/or RNA, and at least one single stranded RNA output strand, wherein no portion of the at least one trigger toehold hybridizes to any portion of the at least one output strand, the at least one trigger toehold is complementary and hybridizes to a first target sequence when the nanoparticle is in the presence of the first target sequence, and the nanoparticle does not contain the target sequence. Related pharmaceutical compositions, methods of treating a patient with a disease or condition, and methods of diagnosing a patient with a disease or condition are also disclosed.
An DNA/RNA hybrid nucleic acid nanoparticle comprising:
(canceled)
(canceled)
Dependencies are inferred from the claim text.